Chronic Granulomatous Disease of Childhood: Clinical, Pathological, Biochemical, Molecular, and Genetic Aspects of the Disease

References

• Berendes H, Bridges R A, Good R A. A fatal granulomatosis of childhood. The clinical study of a new syndrome. Minn Med 1957; 40: 309–12
   PubMedGoogle Scholar
• Landing B H, Shirkey H S. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957; 20: 431–8
   PubMed Web of Science ®Google Scholar
• Carson M J, Chadwick D L, Brubaker C A, Cleland R S, Landing B H. Thirteen boys with progressive septic granulomatosis. Pediatrics 1965; 35: 405–12
   PubMed Web of Science ®Google Scholar
• Holmes B, Page A R, Good R A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest 1967; 46: 1422–32
   PubMed Web of Science ®Google Scholar
• Baehner R L, Nathan D G. Leukocyte oxidase: Defective activity in chronic granulomatous disease. Science 1967; 155: 835–6
   PubMed Web of Science ®Google Scholar
• Baehner R L, Nathan D G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968; 278: 971–6
   PubMed Web of Science ®Google Scholar
• Windhorst D B, Page A R, Holmes B, Quie P G, Good R A. The pattern of genetic transmission of the leukocyte defect in fatal granulomatous disease of childhood. J Clin Invest 1968; 47: 1026–34
   PubMed Web of Science ®Google Scholar
• Verhoeven A J, van Schaik M L J, Roos D, Weening R S. Detection of carriers of the autosomal form of chronic granulomatous disease. Blood 1988; 71: 505–7
   PubMed Web of Science ®Google Scholar
• Quie P G, White J G, Holmes B, Good R A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967; 46: 668–79
   PubMed Web of Science ®Google Scholar
• Babior B M, Curnutte J T, McMurrich B J. The paticulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest 1976; 58: 989–96
   PubMed Web of Science ®Google Scholar
• Rossi F, Zatti M. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes: NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 1964; 20: 21–3
   PubMedGoogle Scholar
• Curnutte J T, Kipnes R S, Babior B M. Defect in pyridine nucleotide dependent superoxide production by a paniculate fraction from the granulocytes of patients with chronic granulomatous disease. N Engl J Med 1975; 293: 628–32
   PubMed Web of Science ®Google Scholar
• Hohn D C, Lehrer R I. NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest 1975; 55: 707–13
   PubMed Web of Science ®Google Scholar
• Patriarch P, Dri P, Kakinuma K, Tedesco F, Rossi F. Studies on the mechanism of metabolic stimulation in polymorphonuclear leucocytes during phagocytosis I. Evidence for superoxide anion involvement in oxidation of NADPH. Biochim Biophys Acta 1975; 385: 380–6
   PubMedGoogle Scholar
• Babior B M, Curnutte J T, Okamura N. The respiratory burst oxidase of the human neutrophil. Oxygen Radicals and Tissue Injury: Proceedings of an Upjohn Symposium. FASEB, Bethesda, Md 1988; 43–8, August, Ga., April 27–29, 1987
   Google Scholar
• Curnutte J T. Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system. J Clin Invest 1985; 75: 1740–3
   PubMed Web of Science ®Google Scholar
• Babior B M. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659–68; 721–25
   PubMed Web of Science ®Google Scholar
• Klebanoff S J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 1968; 95: 2131–8
   PubMed Web of Science ®Google Scholar
• Weiss S J, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982; 70: 598–607
   PubMed Web of Science ®Google Scholar
• Mandell G L, Hook E W. Leukocyte bactericidal activity in chronic granulomatous disease: Correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J Bacteriol 1969; 100: 531–2
   PubMed Web of Science ®Google Scholar
• Johnston R B, Jr, Baehner R L. Chronic granulomatous disease: Correlation between pathogenesis and clinical findings. Pediatrics 1971; 48: 730–9
   PubMed Web of Science ®Google Scholar
• Curnutte J T, Babior B M. Chronic granulomatous disease. Adv Hum Genet 1987; 16: 229–97
   PubMedGoogle Scholar
• Andrews P C, Babior B M. Endogenous protein phosphorylation by resting and activated human neutrophils. Blood 1983; 61: 333–40
   PubMed Web of Science ®Google Scholar
• Segal A W, Heyworth P G, Cockcroft S, Barrowman M M. Stimulated neutrophils from patients with autosomal recessive chronic granulomatous disease fail to phosphorylate a Mr-44,000 protein. Nature 1985; 316: 547–9
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Suzuki K, Suzuki S, Andrews P C, Babior E M. A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils: Evidence from studies with cells from patients with chronic granulomatous disease. J Biol Chem 1986; 261: 9109–15
   PubMed Web of Science ®Google Scholar
• Anderson D C, Schmalstieg F C, Arnaout M A, et al. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): Common relationship to diminished cell adherence. J Clin Invest 1984; 74: 536–51
   PubMed Web of Science ®Google Scholar
• Curnutte J T, Whitten D M, Babior B M. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 1974; 290: 593–7
   PubMed Web of Science ®Google Scholar
• Newburger P E, Cohen H J, Rothchild S B, Hobbins J C, Malawista S E, Mahoney M J. Prenatal diagnosis of chronic granulomatous disease. N Engl J Med 1979; 300: 178–81
   PubMed Web of Science ®Google Scholar
• Segal A W, Cross A R, Garcia R C, et al. Absence of cytochrome b-245 in chronic granulomatous disease: A multicenter European evaluation of its incidence and relevance. N Engl J Med 1983; 308: 245–51
   PubMed Web of Science ®Google Scholar
• Curnutte J T, Berkow R L, Roberts R L, Shurin S B, Scott P J. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation. J Clin Invest 1988; 81: 606–10
   PubMed Web of Science ®Google Scholar
• Borregaard N, Tauber A I. Subcellular localization of the human neutrophil NADPH oxidase b-cytochrome and associated flavoprotein. J Biol Chem 1984; 259: 47–52
   PubMed Web of Science ®Google Scholar
• Teahan C, Rowe P, Parker P, Totty N, Segal A W. The X-linked chronic granulomatous disease gene codes for the beta chain of cytochrome b-245. Naturè 1987; 327: 720–1
   PubMed Web of Science ®Google Scholar
• Giblett E R, Klebanoff S J, Pincus S A, Swanson J, Park B H, McCullough J. Kell phenotypes in chronic granulomatous disease: A potential transfusion hazard. Lancet 1971; 1: 1235–6
   PubMed Web of Science ®Google Scholar
• Marsh W L. Chronic granulomatous disease, the McLeod syndrome, and the Kell blood groups. Birth Defects 1978; 14(6A)9–25
   PubMedGoogle Scholar
• Baehner R L, Kunkel L M, Monaco A P, et al. DNA linkage analysis of X chromosome-linked chronic granulomatous disease. Proc Natl Acad Sci USA 1986; 83: 3398–401
   PubMed Web of Science ®Google Scholar
• Francke U. Random X inactivation resulting in mosaic nullisomy of region Xp21.1–21.3 associated with heterozygosity for ornithine transcarbamylase deficiency and chronic granulomatous disease. Cytogenet Cell Genet 1984; 38: 298–307
   PubMedGoogle Scholar
• Francke U, Ochs H D, de Martinville B, et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985; 37: 250–67
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B, Kunkel L M, Monaco A P, et al. Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location. Nature 1986; 322: 32–8
   PubMed Web of Science ®Google Scholar
• Dinauer M C, Orkin S H, Brown R, Jesaitis A J, Parkos C A. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987; 327: 717–20
   PubMed Web of Science ®Google Scholar
• Curnutte J T, Scott P J, Mayo L A. Cytosolic components of the respiratory burst oxidase: Resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Proc Natl Acad Sci USA 1989; 86: 825–9
   PubMed Web of Science ®Google Scholar
• Volpp B D, Nauseef W M, Clark R A. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 1988; 242: 1295–7
   PubMed Web of Science ®Google Scholar
• Nunoi H, Rotrosen D, Gallin J I, Malech H L. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 1988; 242: 1298–301
   PubMed Web of Science ®Google Scholar
• Clark R A, Malech H L, Gallin J I, et al. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med 1989; 321: 647–52
   PubMed Web of Science ®Google Scholar
• Johnston R B, Jr, Newman S L. Chronic granulomatous disease. Pediatr Clin North Am 1977; 24: 365–76
   PubMed Web of Science ®Google Scholar
• Gallin J I, Buescher E S, Seligmann B E, Nath J, Gaither T, Katz P. NIH Conference. Recent advances in chronic granulomatous disease. Ann Intern Med 1983; 99: 657–74
   PubMed Web of Science ®Google Scholar
• Tauber A I, Borregaard N S, Simons E, Wright J. Chronic granulomatous disease: A syndrome of phagocyte oxidase deficiencies. Medicine 1983; 62: 286–309
   PubMed Web of Science ®Google Scholar
• Weening R S, Adriaansz L H, Weemaes C M, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr 1985; 107: 102–4
   PubMed Web of Science ®Google Scholar
• Ezekowitz R A, Dinauer M C, Jaffe H S, Orkin S H, Newburger P E. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 1988; 319: 146–51
   PubMed Web of Science ®Google Scholar